Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics-Reference-Cited by-同舟云学术

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics

Published:2019-05-06 Issue:2 Volume:15 Page:282-288
ISSN:2225-3653
Container-title:Rational Pharmacotherapy in Cardiology
language:
Short-container-title:Racionalʹnaâ farmakoterapiâ v kardiologii

Author:

Arutyunov G. P.,Boytsov S. A.,Voyevoda M. I.,Gurevich V. S.,Drapkina O. M.,Kukharchuk V. V.,Martynov A. I.,Sergiyenko I. V.,Shestakova M. V.,Aliyeva A. S.,Akhmedzhanov N. M.,Bubnova M. G.,Galyavich А. S.,Gordeyev I. G.,Ezhov M. V.,Karpov Yu. A.,Konstantinov V. O.,Nedogoda S. V.,Nifontov E. M.,Orlova Ya. A.,Panov A. V.,Sayganov S. A.,Skibitskiy V. V.,Tarlovskaya E. I.,Urazgildeyeva S. A.,Khalimov Yu. Sh.

Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference44 articles.

1. WHO newsletter. Cardiovascular diseases [cited by Apr 20, 201 9]. Available from: https: //www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

2. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(1 5):1 503-1 6. doi:10.1056/NEJMoa070829.

3. Chung S.C., Hlatky M.A., Faxon D., et al. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). J Am Coll Cardiol. 2011 ;58(8):810-9. doi:10.1016/j.jacc.2011.05.020.

4. Frye R.L., August P., Brooks M.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503-1 5. doi:10.1056/NEJMoa0805796.

5. Henderson R.A., Pocock S.J., Clayton TC., et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy, J Am Coll Cardiol. 2003;42(7):1 1 61 -70. doi:10.1016/S0735-1097(03)00951-3.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience of treating patients with mixed hypertriglyceridemia in a lipid center (clinical case);Complex Issues of Cardiovascular Diseases;2023-01-11

2. Сlinical portrait of the ambulatory patient with diabetes 2 types;South Russian Journal of Therapeutic Practice;2022-09-01

3. Combined Correction of Experimental Critical Ischemia of the Lower Extremities in a Rat Model;International Journal of Biomedicine;2021-09-09

4. Modern principles of atherogenic dyslipidemia management in special groups of patients;CardioSomatics;2020-09-26

5. Role of omega-3 polyunsaturated fatty acids in cardiovascular risk management;Cardiovascular Therapy and Prevention;2020-07-03